-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Reiterates Outperform on Disc Medicine, Maintains $88 Price Target

Benzinga·06/10/2026 13:57:51
Listen to the news
Wedbush analyst David Nierengarten reiterates Disc Medicine (NASDAQ:IRON) with a Outperform and maintains $88 price target.